STUDY Article: THU-108 Linkage to HCV care and reincarceration following release from New York City jails – M. Akiyami, et al.
Study Aims and Results: Generally, people incarcerated in U.S. jails are not sentenced long enough for HCV diagnosis, disease management and treatment. However, the time in jail is an opportunity to provide linkage to care for people while they are incarcerated and when released. The study was conducted in the New York City jails by jail-based transitional care coordinators who provided HCV education, appointment scheduling, reminder calls, and a community patient navigator when released from jail. The study was conducted from May 15, 2015 – April 14, 2017.
The program enrolled 100 participants; mean age of 45; 59% males, 52% Hispanics, 23% non-Hispanic whites, 19% non-Hispanic blacks, six were other races.
Four percent started treatment while in jail. Within 25 days of release, 26 (30%) of the participants were linked to HCV care, and 16 (18%) stared HCV treatment, but 35 (38%) were lost to follow-up.
Thirty-five (40%) of the prisoners who were released were reincarcerated at least one time within a year of release.
The factors that were associated with improving long-term care included being on methadone, and having an existing primary care provider and feeling socially supported before incarceration.
Conclusion: This preliminary study showed that coordinated care could provide a path to care and treatment for people incarcerated and released from jail.
Editorial Comments: Identifying incarcerated individuals in jail with HCV and providing a pathway to care and treatment is an important strategy in the fight to eliminate HCV. Additional studies are needed to build on the outcomes of this study.Share This Page